Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 670965, 10 pages
http://dx.doi.org/10.1155/2015/670965
Review Article

CT Appearance of Hepatocellular Carcinoma after Locoregional Treatments: A Comprehensive Review

1Department of Radiology, Duke University, Durham, NC 27701, USA
2Department of Radiology, Second University of Naples, 80131 Naples, Italy
3Department of Radiology, Monaldi Hospital, 80131 Naples, Italy
4Department of Interventional Radiology, National Cancer Institute, “Fond. Pascale”, 80131 Naples, Italy
5Department of Radiology, UOC San Severo Hospital, 71016 San Severo, Italy

Received 15 June 2015; Revised 9 September 2015; Accepted 14 September 2015

Academic Editor: Mitsuro Kanda

Copyright © 2015 Daniel Marin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA: A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Liapi and J.-F. H. Geschwind, “Transcatheter and ablative therapeutic approaches for solid malignancies,” Journal of Clinical Oncology, vol. 25, no. 8, pp. 978–986, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. A. E. Alsina, “Liver transplantation for hepatocellular carcinoma,” Cancer Control, vol. 17, no. 2, pp. 83–86, 2010. View at Google Scholar · View at Scopus
  4. J. M. Llovet, “Treatment of hepatocellular carcinoma,” Current Treatment Options in Gastroenterology, vol. 7, no. 6, pp. 431–441, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. D. G. Farmer, M. H. Rosove, A. Shaked, and R. W. Busuttil, “Current treatment modalities for hepatocellular carcinoma,” Annals of Surgery, vol. 219, no. 3, pp. 236–247, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. A. K. P. Shanbhogue, A. B. Karnad, and S. R. Prasad, “Tumor response evaluation in oncology: current update,” Journal of Computer Assisted Tomography, vol. 34, no. 4, pp. 479–484, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Bruix, M. Sala, and J. M. Llovet, “Chemoembolization for hepatocellular carcinoma,” Gastroenterology, vol. 127, supplement 1, no. 5, pp. S179–S188, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Y. Yao, R. Hirose, J. M. LaBerge et al., “A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation,” Liver Transplantation, vol. 11, no. 12, pp. 1505–1514, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Llovet, X. Mas, J. J. Aponte et al., “Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation,” Gut, vol. 50, no. 1, pp. 123–128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. D. S. K. Lu, N. C. Yu, S. S. Raman et al., “Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver,” Radiology, vol. 234, no. 3, pp. 954–960, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Y. Yao, R. K. Kerlan Jr., R. Hirose et al., “Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis,” Hepatology, vol. 48, no. 3, pp. 819–827, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. A. Curley, F. Izzo, P. Delrio et al., “Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients,” Annals of Surgery, vol. 230, no. 1, pp. 1–8, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. T. de Baere, D. Elias, C. Dromain et al., “Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year,” American Journal of Roentgenology, vol. 175, no. 6, pp. 1619–1625, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Solbiati, S. N. Goldberg, T. Ierace et al., “Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes,” Radiology, vol. 205, no. 2, pp. 367–373, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Dromain, T. De Baere, D. Elias et al., “Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up,” Radiology, vol. 223, no. 1, pp. 255–262, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Mendizabal and K. R. Reddy, “Current management of hepatocellular carcinoma,” Medical Clinics of North America, vol. 93, no. 4, pp. 885–900, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Forner, J. M. Llovet, and J. Bruix, “Hepatocellular carcinoma,” The Lancet, vol. 379, no. 9822, pp. 1245–1255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. E. L. Kaplan and P. Meier, “Nonparametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, no. 282, pp. 457–481, 1958. View at Publisher · View at Google Scholar
  19. H. B. El-Serag and A. C. Mason, “Rising incidence of hepatocellular carcinoma in the United States,” The New England Journal of Medicine, vol. 340, no. 10, pp. 745–750, 1999. View at Publisher · View at Google Scholar
  20. J. Bruix and J. M. Llovet, “Major achievements in hepatocellular carcinoma,” The Lancet, vol. 373, no. 9664, pp. 614–616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Franco, L. Capussotti, C. Smadja et al., “Resection of hepatocellular carcinomas—results in 72 European patients with cirrhosis,” Gastroenterology, vol. 98, no. 3, pp. 733–738, 1990. View at Google Scholar · View at Scopus
  22. S. Nakamura, S. Suzuki, and S. Baba, “Resection of liver metastases of colorectal carcinoma,” World Journal of Surgery, vol. 21, no. 7, pp. 741–747, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Ohlsson, U. Stenram, and K.-G. Tranberg, “Resection of colorectal liver metastases: 25-year experience,” World Journal of Surgery, vol. 22, no. 3, pp. 268–277, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Tsuzuki, A. Sugioka, M. Ueda et al., “Hepatic resection for hepatocellular carcinoma,” Surgery, vol. 107, no. 5, pp. 511–520, 1990. View at Google Scholar · View at Scopus
  25. G. Curro, L. Jiao, C. Scisca et al., “Radiofrequency-assisted liver resection in cirrhotic patients with hepatocellular carcinoma,” Journal of Surgical Oncology, vol. 98, no. 6, pp. 407–410, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. K. S. Haghighi, F. Wang, J. King, S. Daniel, and D. L. Morris, “In-line radiofrequency ablation to minimize blood loss in hepatic parenchymal transection,” American Journal of Surgery, vol. 190, no. 1, pp. 43–47, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Germani, M. Pleguezuelo, K. Gurusamy, T. Meyer, G. Isgrò, and A. K. Burroughs, “Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis,” Journal of Hepatology, vol. 52, no. 3, pp. 380–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. M.-S. Chen, J.-Q. Li, Y. Zheng et al., “A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma,” Annals of Surgery, vol. 243, no. 3, pp. 321–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Livraghi, F. Meloni, M. Di Stasi et al., “Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?” Hepatology, vol. 47, no. 1, pp. 82–89, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. N. C. Yu, S. S. Raman, Y. J. Kim, C. Lassman, X. Chang, and D. S. K. Lu, “Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model,” Journal of Vascular and Interventional Radiology, vol. 19, no. 7, pp. 1087–1092, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Llovet and J. Bruix, “Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival,” Hepatology, vol. 37, no. 2, pp. 429–442, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Llovet, M. I. Real, X. Montaña et al., “Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial,” The Lancet, vol. 359, no. 9319, pp. 1734–1739, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. C.-M. Lo, H. Ngan, W.-K. Tso et al., “Randomized controlled trial of transarterial Lipiodol chemoembolization for unresectable hepatocellular carcinoma,” Hepatology, vol. 35, no. 5, pp. 1164–1171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. D. B. Brown, J. E. Gould, D. A. Gervais et al., “Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria,” Journal of Vascular and Interventional Radiology, vol. 20, no. 7, pp. S425–S434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. R. J. Lewandowski, M. F. Mulcahy, L. M. Kulik et al., “Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort,” Radiology, vol. 255, no. 3, pp. 955–965, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. B. Atassi, A. K. Bangash, A. Bahrani et al., “Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay,” Radiographics, vol. 28, no. 1, pp. 81–99, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. J. F. H. Geschwind, R. Salem, B. I. Carr et al., “Yttrium-90 microspheres for the treatment of hepatocellular carcinoma,” Gastroenterology, vol. 127, pp. S194–S205, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Salem, R. J. Lewandowski, B. Atassi et al., “Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival,” Journal of Vascular and Interventional Radiology, vol. 16, no. 12, pp. 1627–1639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Sangro, J. I. Bilbao, J. Boan et al., “Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 66, no. 3, pp. 792–800, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Luo, R.-P. Guo, E. C. H. Lai et al., “Transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein tumor thrombosis: a prospective comparative study,” Annals of Surgical Oncology, vol. 18, no. 2, pp. 413–420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. L. M. Kulik, B. I. Carr, M. F. Mulcahy et al., “Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis,” Hepatology, vol. 47, no. 1, pp. 71–81, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. H. Oliver III and R. L. Baron, “Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls,” Radiology, vol. 201, no. 1, pp. 1–14, 1996. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Kubota, N. Hisa, T. Nishikawa et al., “Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization: comparison of lipiodol-CT, power doppler sonography, and dynamic MRI,” Abdominal Imaging, vol. 26, no. 2, pp. 184–190, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. A. S. Kierans, M. Elazzazi, L. Braga et al., “Thermoablative treatments for malignant liver lesions: 10-year experience of MRI appearances of treatment response,” American Journal of Roentgenology, vol. 194, no. 2, pp. 523–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. S. Kim, L. Mannelli, C. H. Hajdu et al., “Hepatocellular carcinoma: assessment of response to transarterial chemoembolization with image subtraction,” Journal of Magnetic Resonance Imaging, vol. 31, no. 2, pp. 348–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. R. L. Baron, J. H. Oliver III, G. D. Dodd III, M. Nalesnik, B. L. Holbert, and B. Carr, “Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, helical CT,” Radiology, vol. 199, no. 2, pp. 505–511, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. B. I. Choi, H. J. Lee, J. K. Man, D. S. Choi, J. B. Seo, and M. C. Han, “Detection of hypervascular nodular hepatocellular carcinomas: value of triphasic helical CT compared with iodized-oil CT,” American Journal of Roentgenology, vol. 168, no. 1, pp. 219–224, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Iannaccone, A. Laghi, C. Catalane et al., “Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis,” Radiology, vol. 234, no. 2, pp. 460–467, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Wald, M. W. Russo, J. K. Heimbach, H. K. Hussain, E. A. Pomfret, and J. Bruix, “New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma,” Radiology, vol. 266, no. 2, pp. 376–382, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Therasse, S. G. Arbuck, E. A. Eisenhauer et al., “New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada,” Journal of the National Cancer Institute, vol. 92, no. 3, pp. 205–216, 2000. View at Google Scholar
  52. E. A. Eisenhauer, P. Therasse, J. Bogaerts et al., “New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1),” European Journal of Cancer, vol. 45, no. 2, pp. 228–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. World Health Organization (WHO) Handbook for Reporting Results of Cancer Treatment, WHO Offset Publication no. 48, World Health Organization (WHO), Geneva, Switzerland, 1979.
  54. C. Suzuki, H. Jacobsson, T. Hatschek et al., “Radiologic measurements of tumor response to treatment: practical approaches and limitations,” Radiographics, vol. 28, no. 2, pp. 329–344, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. R. Lencioni and J. M. Llovet, “Modified recist (mRECIST) assessment for hepatocellular carcinoma,” Seminars in Liver Disease, vol. 30, no. 1, pp. 52–60, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. European Association for the Study of the Liver and European Organisation for Research and Treatment of Cancer, “EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma,” Journal of Hepatology, vol. 56, no. 4, pp. 908–943, 2012. View at Publisher · View at Google Scholar
  57. V. Yaghmai, C. Besa, E. Kim, J. L. Gatlin, N. A. Siddiqui, and B. Taouli, “Imaging assessment of hepatocellular carcinoma response to locoregional and systemic therapy,” American Journal of Roentgenology, vol. 201, no. 1, pp. 80–96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Memon, L. Kulik, R. J. Lewandowski et al., “Radiographic response to locoregional therapy in hepatocellular carcinoma predicts patient survival times,” Gastroenterology, vol. 141, no. 2, pp. 526–535, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. Y.-S. Kim, H. Rhim, and H. K. Lim, “Imaging after radiofrequency ablation of hepatic tumors,” Seminars in Ultrasound, CT and MRI, vol. 30, no. 2, pp. 49–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. A. B. Miller, B. Hoogstraten, M. Staquet, and A. Winkler, “Reporting results of cancer treatment,” Cancer, vol. 47, no. 1, pp. 207–214, 1981. View at Publisher · View at Google Scholar · View at Scopus
  61. Z. Amin, J. J. Donald, A. Masters et al., “Hepatic metastases: interstitial laser photocoagulation with real-time US monitoring and dynamic CT evaluation of treatment,” Radiology, vol. 187, no. 2, pp. 339–347, 1993. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Rossi, E. Buscarini, F. Garbagnati et al., “Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode,” American Journal of Roentgenology, vol. 170, no. 4, pp. 1015–1022, 1998. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Rossi, M. Di Stasi, E. Buscarini et al., “Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer,” American Journal of Roentgenology, vol. 167, no. 3, pp. 759–768, 1996. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Solbíatí, S. N. Goldberg, T. Ierace, M. Dellanoce, T. Livraghi, and G. S. Gazelle, “Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent—early experience,” Radiology, vol. 211, no. 3, pp. 643–649, 1999. View at Publisher · View at Google Scholar · View at Scopus
  65. L. Solbiati, T. Ierace, S. N. Goldberg et al., “Percutaneous US-guided radio-frequency tissue ablation of liver metastases: teatment and follow-up in 16 patients,” Radiology, vol. 202, no. 1, pp. 195–203, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. S. N. Goldberg, G. S. Gazelle, C. C. Compton, P. R. Mueller, and K. K. Tanabe, “Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation,” Cancer, vol. 88, no. 11, pp. 2452–2463, 2000. View at Google Scholar · View at Scopus
  67. T. Livraghi, S. N. Goldberg, F. Monti et al., “Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases,” Radiology, vol. 202, no. 1, pp. 205–210, 1997. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Seki, M. Wakabayashi, T. Nakagawa et al., “Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma,” Cancer, vol. 74, no. 3, pp. 817–825, 1994. View at Publisher · View at Google Scholar · View at Scopus
  69. K. Ohmoto, I. Miyake, M. Tsuduki et al., “Percutaneous microwave coagulation therapy for unresectable hepatocellular carcinoma,” Hepato-Gastroenterology, vol. 46, no. 29, pp. 2894–2900, 1999. View at Google Scholar · View at Scopus
  70. K. Tabuse and M. Katsumi, “Application of a microwave tissue coagulation to hepatic surgery: the hemostatic effects on spontaneous repture of hepatoma and tumor necrosis,” Nippon Geka Hokan. Archiv für Japanische Chirurgie, vol. 50, pp. 571–579, 1981. View at Google Scholar
  71. R. Murakami, S. Yoshimatsu, Y. Yamashita et al., “Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation,” American Journal of Roentgenology, vol. 164, no. 5, pp. 1159–1164, 1995. View at Publisher · View at Google Scholar · View at Scopus
  72. H. Horigome, T. Nomura, K. Saso, and P. M. Itoh, “Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence,” American Journal of Gastroenterology, vol. 94, no. 7, pp. 1914–1917, 1999. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Fujita, K. Honjo, K. Ito et al., “Fan-shaped hepatic parenchymal damage after ethanol injection therapy for hepatocellular carcinoma: MRI appearances,” Abdominal Imaging, vol. 24, no. 1, pp. 56–60, 1999. View at Publisher · View at Google Scholar · View at Scopus
  74. M. I. Ahn, Y. H. Park, J. I. Yim, and J. Yoo, “Sequential changes of sonographic and computed tomography findings in the normal rabbit liver after percutaneous ethanol injection. Correlation with pathologic findings,” Investigative Radiology, vol. 33, no. 10, pp. 723–729, 1998. View at Publisher · View at Google Scholar · View at Scopus
  75. G. D. Dodd III, M. C. Soulen, R. A. Kane et al., “Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough,” Radiographics, vol. 20, no. 1, pp. 9–27, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. J.-S. Yu, K. W. Kim, K. B. Sung, J. T. Lee, and H. S. Yoo, “Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging,” Radiology, vol. 203, no. 3, pp. 737–742, 1997. View at Publisher · View at Google Scholar · View at Scopus
  77. T. K. Kim, B. I. Choi, J. K. Han, J. W. Chung, J. H. Park, and M. C. Han, “Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings,” Radiology, vol. 208, no. 3, pp. 597–603, 1998. View at Publisher · View at Google Scholar · View at Scopus
  78. D. Mathieu, D. Larde, and N. Vasile, “CT features of iatrogenic hepatic arterioportal fistulae,” Journal of Computer Assisted Tomography, vol. 7, no. 5, pp. 810–814, 1983. View at Publisher · View at Google Scholar · View at Scopus
  79. Y. Itai, S. Furui, K. Ohtomo et al., “Dynamic CT features of arterioportal shunts in hepatocellular carcinoma,” American Journal of Roentgenology, vol. 146, no. 4, pp. 723–727, 1986. View at Publisher · View at Google Scholar · View at Scopus
  80. S. J. Lee, J. H. Lim, W. J. Lee, H. K. Lim, S. W. Choo, and I. W. Choo, “Transient subsegmental hepatic parenchymal enhancement on dynamic CT: a sign of postbiopsy arterioportal shunt,” Journal of Computer Assisted Tomography, vol. 21, no. 3, pp. 355–360, 1997. View at Publisher · View at Google Scholar · View at Scopus
  81. H.-C. Kim, A. Y. Kim, J. K. Han et al., “Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images,” Radiology, vol. 225, no. 3, pp. 773–780, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. T. W. I. Clark, “Complications of hepatic chemoembolization,” Seminars in Interventional Radiology, vol. 23, no. 2, pp. 119–125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. A. J. Lee, A. S. Gomes, D. M. Liu, S. T. Kee, C. T. Loh, and J. P. McWilliams, “The road less traveled: importance of the lesser branches of the celiac axis in liver embolotherapy,” Radiographics, vol. 32, no. 4, pp. 1121–1132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. S. J. Wigmore, D. N. Redhead, B. N. J. Thomson et al., “Postchemoembolisation syndrome—tumour necrosis or hepatocyte injury?” British Journal of Cancer, vol. 89, no. 8, pp. 1423–1427, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. Y. K. Cho, J. K. Kim, M. Y. Kim, H. Rhim, and J. K. Han, “Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies,” Hepatology, vol. 49, no. 2, pp. 453–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  86. F. Fiore, M. Del Prete, R. Franco et al., “Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors,” Endocrine, vol. 47, no. 1, pp. 177–182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. B. Gray, G. Van Hazel, M. Hope et al., “Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer,” Annals of Oncology, vol. 12, no. 12, pp. 1711–1720, 2001. View at Publisher · View at Google Scholar · View at Scopus
  88. B. N. Gray, M. A. Burton, D. Kelleher, P. Klemp, and L. Matz, “Tolerance of the liver to the effects of yttrium-90 radiation,” International Journal of Radiation Oncology, Biology, Physics, vol. 18, no. 3, pp. 619–623, 1990. View at Publisher · View at Google Scholar · View at Scopus
  89. J. E. Goin, R. Salem, B. I. Carr et al., “Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities,” Journal of Vascular and Interventional Radiology, vol. 16, part 1, no. 2, pp. 205–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  90. J. C. Andrews, S. C. Walker, R. J. Ackermann et al., “Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up,” Journal of Nuclear Medicine, vol. 35, no. 10, pp. 1637–1646, 1994. View at Google Scholar · View at Scopus
  91. O. M. Ebied, M. P. Federle, B. I. Carr et al., “Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma,” Cancer, vol. 97, no. 4, pp. 1042–1050, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. P. D. Shreve, Y. Anzai, and R. L. Wahl, “Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants,” Radiographics, vol. 19, no. 1, pp. 61–77, 1999. View at Publisher · View at Google Scholar · View at Scopus
  93. L. M. Kulik, B. Atassi, L. van Holsbeeck et al., “Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation,” Journal of Surgical Oncology, vol. 94, no. 7, pp. 572–586, 2006. View at Publisher · View at Google Scholar · View at Scopus
  94. A. L. Keppke, R. Salem, D. Reddy et al., “Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres,” American Journal of Roentgenology, vol. 188, no. 3, pp. 768–775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  95. R. Salem, R. J. Lewandowski, B. Atassi et al., “Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (therasphere): safety, tumor response, and survival,” Journal of Vascular and Interventional Radiology, vol. 16, no. 12, pp. 1627–1639, 2005. View at Publisher · View at Google Scholar · View at Scopus
  96. R. Salem and K. G. Thurston, “Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: Technical and methodologic considerations,” Journal of Vascular and Interventional Radiology, vol. 17, no. 8, pp. 1251–1278, 2006. View at Publisher · View at Google Scholar
  97. J. E. Dancey, F. A. Shepherd, K. Paul et al., “Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres,” Journal of Nuclear Medicine, vol. 41, no. 10, pp. 1673–1681, 2000. View at Google Scholar · View at Scopus